CHEPLAPHARM Arzneimittel GmbH


This section provides relevant information as well as ongoing and timely updates on the strategic and operative success stories of our steadily growing Company.


Your contact persons

Jens Remmers

Head of Treasury & Investor Relations

IR center of information

Financial Reports

1st December 2022
Earnings Call Q3 2022 Results
29th November 2022
Publication Quarterly Report Q3 2022
1st September 2022
Earnings Call H1 2022 Results
29th August 2022
Publication 1st Half-Year Report 2022
2nd June 2022
Investor Call Quarterly Report Q1 2022
31st May 2022
Publication Quarterly Report Q1 2022
10th May 2022
Investor Call Full Financial Year 2021 audited
29th April 2022
Publication Full Financial Year 2021 audited
30th November 2021
Investor Call Quarterly Report Q3 2021
19th November 2021
Publication Quarterly Report Q3 2021
24th August 2021
Investor Call Quarterly Report Q2 2021
20th August 2021
Publication Quarterly Report Q2 2021
Find out how you can benefit


The latest from CHEPLAPHARM

CHEPLAPHARM acquires global rights to Questran® from Bristol-Myers Squibb

CHEPLAPHARM Arzneimittel GmbH continues with its diversification strategy.

QUESTRAN® is a prescription drug that is registered in 20 countries worldwide - France, United Kingdom, Italy, Brazil and Germany being the top 5 countries.
Containing the active ingredient Cholestyramine, QUESTRAN® is mainly used to reduce the risk of heart attack and stroke in patients with primary hypercholesterolemia.

“With the acquisition and integration of QUESTRAN® into our product portfolio, we do not only continue the very successful cooperation with Bristol-Myers Squibb, but we also reinforce our International Footprint in the respective territories”, said CEO Sebastian F. Braun.

After years of successful development of the global partner network, CHEPLAPHARM further continues its long-term success story by scaling the business model.

Press Office:
CHEPLAPHARM Arzneimittel GmbH | Ziegelhof 24 | 17489 Greifswald | presse(at)

Investor Relations topics

Back to top expand_less